• Sarepta Therapeutics average ebitda margin for 2023 was -41.12%, a 19.95% decline from 2022.
• Sarepta Therapeutics average ebitda margin for 2022 was -51.37%, a 38.51% decline from 2021.
• Sarepta Therapeutics average ebitda margin for 2021 was -83.54%, a 36.21% decline from 2020.

Ebitda margin can be defined as earnings before interest, taxes, depreciation and amortization as a portion of total revenue.